Perrigo (NYSE:PRGO) Share Price Passes Above Two Hundred Day Moving Average - Here's What Happened

Key Points

• Perrigo shares rose above their 200-day moving average, reaching $13.76 and last trading near $13.66, compared with the average of $11.43.
• Analyst sentiment remains mixed, with a consensus “Hold” rating and an average price target of $19.33. One firm upgraded the stock to “Buy,” while another improved its rating from “Sell (D-)” to “Sell (D).”
• Perrigo reported quarterly EPS of $0.50, beating estimates of $0.39, while revenue was $1.02 billion and declined 3.1% year over year. The company also declared a $0.29 quarterly dividend, representing an annualized yield of approximately 8.5%.

Shares of Perrigo Company plc (NYSE:PRGO - Get Free Report) passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $11.43 and traded as high as $13.76. Perrigo shares last traded at $13.6630, with a volume of 1,828,665 shares changing hands.

Analyst Upgrades and Downgrades

Several brokerages recently commented on PRGO. Wall Street Zen raised Perrigo from a "hold" rating to a "buy" rating in a research note on Saturday, August 8th. Weiss Ratings upgraded Perrigo from a "sell (d-)" rating to a "sell (d)" rating in a research note on Thursday, August 6th. One investment analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Perrigo presently has a consensus rating of "Hold" and an average target price of $19.33.

Perrigo Price Performance

The stock's 50-day moving average price is $12.33 and its 200-day moving average price is $11.43. The company has a market capitalization of $1.90 billion, a price-to-earnings ratio of -1.09, a price-to-earnings-growth ratio of 1.56 and a beta of 0.59. The company has a quick ratio of 1.32, a current ratio of 2.32 and a debt-to-equity ratio of 1.31.

Perrigo (NYSE:PRGO - Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $0.50 EPS for the quarter, topping analysts' consensus estimates of $0.39 by $0.11. The firm had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.02 billion. Perrigo had a positive return on equity of 11.25% and a negative net margin of 41.85%.The company's revenue was down 3.1% on a year-over-year basis. During the same period last year, the company earned ($0.06) earnings per share. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. Equities research analysts anticipate that Perrigo Company plc will post 2.18 earnings per share for the current year.

Perrigo Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Friday, August 28th will be issued a $0.29 dividend. This represents a $1.16 annualized dividend and a yield of 8.5%. The ex-dividend date is Friday, August 28th. Perrigo's dividend payout ratio is currently -9.27%.

Institutional Trading of Perrigo

A number of institutional investors have recently bought and sold shares of the business. Sequoia Financial Advisors LLC acquired a new position in shares of Perrigo in the 2nd quarter valued at $207,000. WINTON GROUP Ltd lifted its stake in Perrigo by 52.9% in the second quarter. WINTON GROUP Ltd now owns 75,700 shares of the company's stock valued at $787,000 after buying an additional 26,200 shares during the period. Engineers Gate Manager LP lifted its stake in Perrigo by 28.4% in the second quarter. Engineers Gate Manager LP now owns 151,869 shares of the company's stock valued at $1,578,000 after buying an additional 33,554 shares during the period. Integrated Wealth Concepts LLC bought a new position in Perrigo during the second quarter worth about $126,000. Finally, Allworth Financial LP boosted its holdings in Perrigo by 489.1% during the second quarter. Allworth Financial LP now owns 9,390 shares of the company's stock worth $98,000 after buying an additional 7,796 shares during the last quarter. Institutional investors and hedge funds own 95.91% of the company's stock.

Perrigo Company Profile

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo's focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo's operations span research and development, manufacturing, quality assurance and global distribution.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.